Keyphrases
Bronchiectasis
92%
Microbiome
53%
Inflammatory Endotype
27%
Chronic Obstructive Pulmonary Disease
27%
Exacerbation Risk
24%
Sputum
22%
Airway
21%
Bacterial Load
20%
Airway Microbiome
20%
EMBARC
19%
Sputum Microbiome
19%
European multicentre Study
18%
Inhaled Corticosteroids
18%
Disease Overlap
18%
Randomized Controlled Trial
18%
Multicenter Cohort Study
18%
Molecular Endotype
18%
Microbial Diversity
15%
Microbial Profile
15%
Fluticasone Propionate
12%
Salmeterol
12%
Budesonide
12%
Disease Severity
10%
Rate Ratio
9%
Cluster Analysis
9%
Proteobacteria
9%
Endograft
9%
Popliteal Artery Aneurysm
9%
Airway Disease
9%
Aspergillus Sensitization
9%
Aspergillus
9%
Treatable Traits
9%
Cancer Development
9%
Single-center Experience
9%
Respiratory Disease
9%
Macrolide Antibiotics
9%
Clinical Outcomes
9%
Ring Structure
9%
Nitinol
9%
Neutrophil Extracellular Traps
9%
Immunomodulatory Effect
9%
Respiratory Cancer
9%
Microbiome Structure
9%
Endovascular
9%
Abdominal
9%
Multi-cohort Studies
9%
Prospective Observational Study
9%
Aneurysm Repair
9%
Antibiotic Response
9%
Respiratory Infection
9%
Immunology and Microbiology
Microbiome
100%
Sputum
61%
Bacterial Load
22%
Random Forest
16%
Formoterol
16%
Proteobacteria
15%
Taxon
13%
Prevotella
13%
Phylum
12%
Neisseria
12%
Campylobacter
12%
Fluticasone/Salmeterol
12%
Budesonide
12%
Pseudomonas
10%
Mucin
9%
Infectious Agent
9%
Neutrophil Extracellular Traps
9%
Streptococcus
8%
Haemophilus
7%
Neutrophil
6%
Microbial Diversity
6%
Fusobacterium
6%
Arm
6%
Amplicon Sequencing
5%
Medicine and Dentistry
Microbiome
49%
Bronchiectasis
45%
Chronic Obstructive Pulmonary Disease
29%
Endotype
28%
Sputum
27%
Budesonide/Formoterol
18%
Fluticasone
18%
Salmeterol
18%
Randomized Controlled Trial
18%
Cohort Analysis
9%
Neutrophil
9%
Respiratory Tract Infection
9%
Extracellular Trap
9%
Lung Cancer
9%
Pathogen
9%
Popliteal Artery Aneurysm
9%
Disease Severity
9%
Limb
9%
Nitinol
9%
Cluster Analysis
7%
Malignant Neoplasm
6%
Formoterol
6%
Stent-Graft
5%
Proteobacteria
5%
RNA 16S
5%
Disease
5%